GlassScriptPhysician profile
Steven Lee Pike
NPI 1205226255
$6,525.47
in general payments reported to CMS, 2019-2025
34 companies · $482 in 2025
The $482 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $821 · 2021: $788 · 2022: $1,221 · 2023: $2,820 · 2024: $192 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864 · Travel and Lodging: $1,630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,864.39 |
| Travel and Lodging | $1,629.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $3,335.93 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $624.67 | 2021-2024 | Endocross Device, Torus Stent Graft System |
| Janssen Pharmaceuticals, INC | $294.96 | 2020-2022 | |
| Depuy Synthes Sales INC. | $260.88 | 2025 | Matrixrib |
| Biom'Up France Sas | $236.78 | 2020 | |
| Bard Peripheral Vascular, INC. | $198.43 | 2020-2022 | |
| Boston Scientific Corporation | $192.66 | 2020-2023 | Varithena Administration Pack |
| Medtronic, INC. | $141.26 | 2021-2025 | Endurant Iis, Ligasure |
| Cook Medical LLC | $139.72 | 2019-2024 | Cook |
| Truvic Medical, INC. | $135.18 | 2022 | |
| W. L. Gore & Associates, INC. | $103.47 | 2022-2025 | Gore Tag Conformable Thoracic Stent Graft, Gore Excluder Iliac Branch Endoprosthesis |
| Surmodics, INC. | $90.72 | 2022-2025 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Artivion, INC. | $72.63 | 2019-2024 | Vascular |
| Atricure, INC. | $69.82 | 2019 | |
| Shockwave Medical, INC | $68.37 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $63.49 | 2020-2024 | Artegraft Vascular Graft, Restoreflow |
| Avinger INC. | $61.58 | 2020-2021 | |
| Smith+Nephew, INC. | $52.57 | 2021-2022 | |
| Kerecis Limited | $39.98 | 2020-2021 | |
| Becton, Dickinson and Company | $38.19 | 2023 | Venclose Maven Catheter |
| Medistim USA, INC. | $30.86 | 2020 | |
| Biom'Up Sa | $30.18 | 2019 | |
| Convatec INC. | $29.48 | 2023 | |
| Penumbra, INC. | $28.60 | 2024 | Indigo System |
| Octapharma USA, INC. | $23.75 | 2025 | Fibryga |
| Kci USA, INC. | $23.67 | 2021 | |
| Acell, INC. | $23.40 | 2019 | |
| Cardiovascular Systems INC. | $20.01 | 2022 | |
| Sanara Medtech INC. | $18.09 | 2022 | |
| Teleflex LLC | $17.78 | 2025 | Manta |
| Biocompatibles, INC. | $17.76 | 2019 | |
| Philips North America LLC | $14.73 | 2019 | |
| Getinge USA Sales, LLC | $13.96 | 2021 | |
| Ekos Corporation | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Pike listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.